Dyck PJ - Search Results

1

Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial.

Ziegler D, Low PA, Litchy WJ, Boulton AJ, Vinik AI, Freeman R, Samigullin R, Tritschler H, Munzel U, Maus J, Schütte K, Dyck PJ. Ziegler D, et al. Among authors: dyck pj. Diabetes Care. 2011 Sep;34(9):2054-60. doi: 10.2337/dc11-0503. Epub 2011 Jul 20. Diabetes Care. 2011. PMID: 21775755 Free PMC article. Clinical Trial.

2

The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.

Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ, Low PA, Nehrdich D, Novosadova M, O'Brien PC, Reljanovic M, Samigullin R, Schuette K, Strokov I, Tritschler HJ, Wessel K, Yakhno N, Ziegler D; SYDNEY Trial Study Group. Ametov AS, et al. Among authors: dyck pj. Diabetes Care. 2003 Mar;26(3):770-6. doi: 10.2337/diacare.26.3.770. Diabetes Care. 2003. PMID: 12610036 Clinical Trial.

3

Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.

Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J, Samigullin R. Ziegler D, et al. Among authors: dyck pj. Diabetes Care. 2006 Nov;29(11):2365-70. doi: 10.2337/dc06-1216. Diabetes Care. 2006. PMID: 17065669 Clinical Trial.

4

Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity.

Dyck PJ, Norell JE, Tritschler H, Schuette K, Samigullin R, Ziegler D, Bastyr EJ 3rd, Litchy WJ, O'Brien PC. Dyck PJ, et al. Diabetes Care. 2007 Oct;30(10):2619-25. doi: 10.2337/dc06-2479. Epub 2007 May 18. Diabetes Care. 2007. PMID: 17513707

5

Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy.

Dyck PJ, O'Brien PC, Litchy WJ, Harper CM, Klein CJ, Dyck PJ. Dyck PJ, et al. Diabetes Care. 2005 Sep;28(9):2192-200. doi: 10.2337/diacare.28.9.2192. Diabetes Care. 2005. PMID: 16123489

6

Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments.

Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P; Toronto Diabetic Neuropathy Expert Group. Tesfaye S, et al. Among authors: dyck pj. Diabetes Care. 2010 Oct;33(10):2285-93. doi: 10.2337/dc10-1303. Diabetes Care. 2010. PMID: 20876709 Free PMC article. Review.

7

Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathy.

Dyck PJ, Carter RE, Litchy WJ. Dyck PJ, et al. Muscle Nerve. 2011 Sep;44(3):340-5. doi: 10.1002/mus.22074. Muscle Nerve. 2011. PMID: 21996793 Free PMC article.

8

Impaired glycemia and diabetic polyneuropathy: the OC IG Survey.

Dyck PJ, Clark VM, Overland CJ, Davies JL, Pach JM, Dyck PJ, Klein CJ, Rizza RA, Melton LJ 3rd, Carter RE, Klein R, Litchy WJ. Dyck PJ, et al. Diabetes Care. 2012 Mar;35(3):584-91. doi: 10.2337/dc11-1421. Diabetes Care. 2012. PMID: 22355020 Free PMC article.

9

Autonomic symptoms and diabetic neuropathy: a population-based study.

Low PA, Benrud-Larson LM, Sletten DM, Opfer-Gehrking TL, Weigand SD, O'Brien PC, Suarez GA, Dyck PJ. Low PA, et al. Among authors: dyck pj. Diabetes Care. 2004 Dec;27(12):2942-7. doi: 10.2337/diacare.27.12.2942. Diabetes Care. 2004. PMID: 15562211

10

Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes.

Dyck PJ, Davies JL, Clark VM, Litchy WJ, Dyck PJ, Klein CJ, Rizza RA, Pach JM, Klein R, Larson TS, Melton LJ 3rd, O'Brien PC. Dyck PJ, et al. Diabetes Care. 2006 Oct;29(10):2282-8. doi: 10.2337/dc06-0525. Diabetes Care. 2006. PMID: 17003307

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

609 results

Search Page